In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: MetLife’s current price at $98.27 sits significantly below the $147.90 fair value, indicating a 50.5% implied upside with high valuation confidence. Financial health scores highlight fair liquidity and leverage but low efficiency and growth, increasing risk. Monte Carlo analysis reveals wide valuation volatility and a 36.1% chance of downside below the current price.